Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

Objectives: Currently there are no standard biomarkers of head and neck squamous cell carcinoma (HNSCC) response to therapy. This is, due to a lack of adequate predictive tumor models. To this end, we established cancer organoid lines from individual patient's tumors, and characterized their gr...

Full description

Bibliographic Details
Main Authors: Lindemann, A. (Author), Myers, J.N (Author), Osman, A.A (Author), Patel, A.A (Author), Takahashi, H. (Author), Takahashi, Y. (Author), Tanaka, N. (Author), Zhao, M. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2018
Subjects:
Online Access:View Fulltext in Publisher